Summary:
A research study evaluating blood samples collected from lung cancerand pulmonary nodule patients to assist in future diagnostic test development
Qualified Participants Must:
• Be between 35 and 79 years of age
•
Have Pulmonary Nodules or Lung Cancer
•
Have been scheduled for a lung biopsy or other diagnostic procedure due to suspicion of lung cancer, or have had a recent CT scan showing a pulmonary nodule > 4mm
•
Do not have a prior history of cancer (with the exception of non-melanoma skin cancer)
•
Have not had prior removal of the lung (with the exception of lung biopsies)
•
Have not received any cytotoxic therapy, such as chemotherapy or radiation therapy
Qualified Participants May Receive:
Financial compensation may be provided for time and travel expenses.
Patent commitment duration: Single visit
Number of visits in study: Single visit